NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,169 | +0.9% | 11,476 | 0.0% | 0.12% | +1.6% |
| Q2 2023 | $1,158 | +9.7% | 11,476 | 0.0% | 0.12% | +6.1% |
| Q1 2023 | $1,056 | +1.4% | 11,476 | 0.0% | 0.12% | 0.0% |
| Q4 2022 | $1,041 | -99.9% | 11,476 | 0.0% | 0.12% | +23.7% |
| Q3 2022 | $872,000 | -10.1% | 11,476 | 0.0% | 0.09% | -27.9% |
| Q2 2022 | $970,000 | -3.7% | 11,476 | 0.0% | 0.13% | +25.2% |
| Q1 2022 | $1,007,000 | -0.5% | 11,476 | -0.8% | 0.10% | +24.1% |
| Q4 2021 | $1,012,000 | +8.7% | 11,571 | +1.6% | 0.08% | +7.8% |
| Q3 2021 | $931,000 | -9.6% | 11,386 | +0.8% | 0.08% | -12.5% |
| Q2 2021 | $1,030,000 | +6.7% | 11,291 | 0.0% | 0.09% | +14.3% |
| Q1 2021 | $965,000 | -9.5% | 11,291 | 0.0% | 0.08% | -17.2% |
| Q4 2020 | $1,066,000 | +8.6% | 11,291 | 0.0% | 0.09% | -47.2% |
| Q3 2020 | $982,000 | -0.4% | 11,291 | 0.0% | 0.18% | -6.4% |
| Q2 2020 | $986,000 | +5.9% | 11,291 | 0.0% | 0.19% | -5.5% |
| Q1 2020 | $931,000 | – | 11,291 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |